INmune Bio Inc. received an International Search Report and Written Opinion confirming the novelty, inventive step, and industrial applicability of its patent application for its proprietary cell line and therapeutic composition. They also announced the presentation of data on the use of INB03 in breast cancer treatment at an upcoming conference.